Skip to main content
profile image
Selected Works of Doured Daghistani
Article
Pediatric and Adult H3 K27M-mutant Diffuse Midline Glioma Treated With the Selective DRD2 Antagonist ONC201
Journal of neuro-oncology (2019)
  • Doured Daghistani, Nicklaus Children's Hospital, Miami, FL.
  • Andrew S. Chi
  • Rohinton Tarapore, Oncoceutics, Philadelphia, PA
  • Matthew D. Hall, Radiation Oncology, Miami Cancer Institute
  • Nicole A. Shonka, University of Nebraska Medical Center
  • Sharon Gardner, NYU Langone Health and School of Medicine, New York
  • Yoshie Umemura, University of Michigan
  • Ashley Sumrall, Levine Cancer Institute, Charlotte, NC;
  • Ziad Khatib, Nicklaus Children's Hospital, Miami FL
  • Sabine Mueller, University of California, San Francisco
  • Cassie Kline
  • Wafik Zaky, University of Texas MD Anderson Cancer Center
  • Soumen Khatua, University of Texas MD Anderson Cancer Center
  • Shiao-Pei Weathers
  • Yazmin Odia, Radiation Oncology, Miami Cancer Institute
  • Toba N. Niazi, Nicklaus Children's Hospital, Miami, FL
  • Irene Cherrick
  • David Korones
  • Matthias Karajannis, Memorial Sloan Kettering Cancer Center
  • Xiao-Tang Kong
  • Jane Minturn
  • Angela Waanders
  • Irene Cherrick
  • Isabel Arillaga-Romany
  • Tracy Batchelor, Massachusetts General Hospital, Boston, MA
  • Patrick Y. Wen
  • Krystal Merdinger
  • Lee Schalop, Oncoceutics, Philadelphia, PA
  • Martin Stogniew
  • Joshua E. Allen
  • Wolfgang Oster, Oncoceutics, Inc., Philadelphia, PA, USA
  • Minesh Mehta, Radiation Oncology, Miami Cancer Institute
Link
Disciplines
Publication Date
October, 2019
DOI
https://doi.org/10.1007/s11060-019-03271-3
Citation Information
Doured Daghistani, Andrew S. Chi, Rohinton Tarapore, Matthew D. Hall, et al.. "Pediatric and Adult H3 K27M-mutant Diffuse Midline Glioma Treated With the Selective DRD2 Antagonist ONC201" Journal of neuro-oncology Vol. 145 Iss. 1 (2019) p. 97 - 105
Available at: http://works.bepress.com/doured-daghistani/18/